Content Stream

Study Shows Anti-Viral Medicine Reduces Flu Symptoms in People With High-Risk Conditions, Like Asthma

Genentech, a member of the Roche Group, today announced that the Phase III CAPSTONE-2 study assessing the safety and efficacy of baloxavir marboxil in people at high risk of complications from the flu met the study’s primary objective, and showed superior efficacy in the primary endpoint of time to improvement of influenza symptoms versus placebo.

High Heat, Air Pollution, Air Quality Create Problems for People with Asthma

When we think of summer, we usually think of outdoor fun like swimming, cookouts, sporting events and going to the park. But with summer also comes a combination of heat and smog that can create bad air quality. Heat, air pollution and ragweed pollen create problems in the fall too. Since we spend more time outside in these warmer months, these combinations can be hard on your airways.

New Pediatric Asthma Yardstick Provides Health Care Professionals a Roadmap for Managing Asthma in Children

Although about 10 percent of school-aged children in the United States have asthma, there are few comprehensive U.S. guidelines for treating pediatric asthma. The Pediatric Asthma Yardstick, a new guideline from the American College of Allergy, Asthma and Immunology (ACAAI), offers a user-friendly “operational document”. It helps health care professionals understand which controller treatments are right for which age groups and identifies when a step up is needed.

×
×
×
×